FDA Says Yes to Cryoablation for Early Breast Cancer



(MedPage Today) — The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older women not suitable for surgery, maker IceCure announced.
A minimally invasive tool that destroys tumors…



Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/117812

Author :

Publish date : 2025-10-06 18:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version